Unilever PLC (UL) Q2 2024 Earnings Call Transcript
Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
Overview
The earnings call reveals strong financial performance with significant growth in sales, volume, and operating profit, alongside a notable dividend increase and share buyback program. Despite challenges like currency fluctuations and increased tax rates, optimistic guidance and operational improvements are highlighted. The Q&A section supports this with positive expectations for emerging markets and market share gains. The overall sentiment, bolstered by strategic shareholder returns, suggests a positive stock price movement.
Key Financial Performance
Underlying Sales Growth 4.1%, up from previous year
Volume Growth 2.6%, up from previous year
Gross Margin 45.7%, up 420 basis points from previous year
Underlying Operating Profit €6.1 billion, up 17.1% from previous year
Underlying Operating Margin 19.6%, up 250 basis points from previous year
Underlying Earnings Per Share €1.62, up 16.3% from previous year
Free Cash Flow €2.2 billion, down €300 million from previous year
Turnover €31.1 billion, up 2.3% from previous year
Brand and Marketing Investment 15.1% of turnover, up 180 basis points from previous year
Net Finance Costs as a Percentage of Average Net Debt 2.9%, expected to be around 3% for the full year
Tax Rate 26%, up from previous year, impacting underlying EPS by 3.2%
You have reached the limit. Sign up to access full content
Get started
Operating Highlights
New Product Launches: Launch of Persil Wonder Wash, a technology-based detergent for short-cycle washes, already successful in the UK, France, and China, with plans for further rollout.
Market Expansion: Distribution expansion in China focusing on premium products and high consumption potential provinces.
Geographic Performance: Strong performance in developed markets, particularly in Europe and North America, with a focus on innovation and brand investment.
Operational Efficiencies: Gross margin expanded by 420 basis points to 45.7%, driven by lower material costs and tight cost control.
Productivity Drive: Company-wide productivity drive aimed at simplifying operations and enhancing decision-making.
Strategic Shifts: Separation of Ice Cream business to enhance long-term performance, with completion expected by the end of 2025.
Growth Action Plan: Implementation of the Growth Action Plan focusing on faster high-quality growth, streamlined operations, and a performance culture.
You have reached the limit. Sign up to access full content
Get started
Risk or Challenges
Competitive Pressures: Despite operational improvements in the Ice Cream business, performance has been disappointing, particularly in China and Europe, due to market conditions and competitive pressures.
Regulatory Issues: The company is facing challenges in Indonesia, exacerbated by consumer reactions against multinational brands due to geopolitical situations, which may require significant portfolio initiatives.
Supply Chain Challenges: The company anticipates increases in replenishment costs for key materials due to a moderate return of commodity inflation, impacting margins.
Economic Factors: Weakening consumer sentiment in North America and expected consumption slowdown in Argentina may affect overall sales growth.
Operational Improvements: The need for continued operational improvements is emphasized, particularly in the Ice Cream business, to enhance competitiveness and service.
Currency Fluctuations: Currency had an adverse impact on turnover and EPS, reflecting the challenges posed by currency strength against other currencies.
Tax Rate Increase: An increase in the underlying effective tax rate to 26% is expected to remain for the full year, impacting earnings.
Working Capital: Higher seasonal outflow in working capital and increased capital expenditure have negatively affected free cash flow.
You have reached the limit. Sign up to access full content
Get started
Guidance & Outlook
Growth Action Plan (GAP): The Growth Action Plan is key to improving performance and restoring competitiveness, focusing on faster high-quality growth, streamlining the business, and embedding a sharper performance culture.
Investment in Power Brands: Increased brand and marketing investment by 180 basis points to 15.1% of turnover, with 85% of the incremental increase allocated to Power Brands.
Innovation Scaling: Focus on leveraging brand strength and R&D capabilities to scale innovations effectively, aiming to double the average size of innovations and drive select projects to over €100 million by 2025.
Separation of Ice Cream: The separation of the Ice Cream business is on track to be completed by the end of 2025, aimed at enhancing long-term interests for both Unilever and Ice Cream.
2024 Underlying Sales Growth: Expected to be within the multi-year range of 3% to 5%, primarily driven by volume.
2024 Underlying Operating Margin: Expected to be at least 18% for the full year.
Capital Expenditure: Expected to be around 3% of turnover for the full year.
Quarterly Interim Dividend: Increased by 3%, marking the first increase since Q4 2020.
Net Finance Costs: Expected to be around 3% of average net debt for the full year.
Effective Tax Rate: Expected to remain at around 26% for the full year.
You have reached the limit. Sign up to access full content
Get started
Shareholder Return Plan
Quarterly Interim Dividend Increase: The Unilever Board has decided to increase the quarterly interim dividend by 3%, marking the first increase since Q4 2020.
Share Buyback Program: In February 2024, Unilever announced a share buyback program of up to €1.5 billion to be conducted during 2024. The first tranche of €850 million commenced in May and is expected to complete on or before August 30, 2024.
You have reached the limit. Sign up to access full content
Get started
Key Q&A
Q:Are you still expecting volume growth to accelerate in the second half versus the Q2 level of 2.9%?
A:We expect roughly similar volume-led growth in the second half as in the first half, sticking to our full year guidance of 3% to 5%.
Q:Could you elaborate about the potential for gross margin level going forward?
A:We aim to restore gross margin to pre-COVID levels and expect most improvements to come from volume leverage, positive mix, and capital expenditure focused on margin expansion.
Q:Why do you think the U.S. beauty category is slowing down, particularly in skincare?
A:We don't think it's structural; some brands are still performing well, and we will continue to invest in our strong brands.
Q:When do you expect the business winning market share metrics to improve?
A:We see green shoots in market share over the last 12 weeks and expect improvements in the second half of the year.
Q:Do you see any reason to be concerned about the medium to longer term trajectory for emerging markets?
A:We remain optimistic about emerging markets due to population growth and the emergence of the middle class.
Q:What percentage of your portfolio will have some kind of renewal in it by the end of the year?
A:We expect roughly two-thirds to 70% of the portfolio to be assessed for unmissable brand superiority.
Q:What does your infrastructure look like in three years’ time?
A:We are investing in increasing productivity and maintaining a good balance between our own manufacturing and third-party suppliers.
Q:What are Heiko Schieper's thoughts on nutrition?
A:Heiko sees a healthy nutrition business focused on condiments, cooking aids, and food solutions, with plans to grow key brands.
Q:What actions are being taken across Europe, North America, and China for Ice Cream?
A:We have improved service, restored competitiveness in pricing, and are working on execution and operations.
Q:What is the outlook for pricing?
A:We expect inflation to normalize, leading to slightly higher pricing levels, but not as high as in 2021 and 2022.
Q:What is the scale of the Health and Wellbeing business?
A:Health and Wellbeing is around €2.5 billion for the year.
Q:What was the net productivity in the cost of goods sold for the first half?
A:We have made progress, but only 5% to 10% of the €800 million savings plan has been implemented.
Q:What is the gross margin progression for Power Brands?
A:Power Brands operate at 400 to 500 basis points higher gross margin than the rest of the portfolio.
Q:Review of Unclear Management Responses
A:Management avoided giving a direct answer regarding the specific growth metrics for the Health and Wellbeing business and the exact percentage of the portfolio undergoing renewal. Additionally, there was a lack of clarity on the specific actions being taken to improve Ice Cream performance across different regions.
You have reached the limit. Sign up to access full content
Get started
Earnings Word Cloud
The most frequently occurring keywords in this quarter's earning call
Asia
Auli
BB
Celine
China market
EBIT margin
Europe North
Guillaume
Hellmann
Hi
Indonesia
North America
Power Brands
aid
beauty
brand marketing
commodity
condition
couple
digit
expansion margin
food solution
health wellness
increase
innovation
interest
investment brand
luxury
marketing investment
nutrition
productivity cost
region
restaurant
separation
service
side
slowdown
story
track
trend
UL Transcript
Unilever PLC (UL) Presents at 23rd annual dbAccess Global Consumer Conference Transcript
Neutral6-3
Unilever PLC (UL) Presents at Consumer Analyst Group of New York Conference 2026 Prepared Remarks Transcript
Neutral2-17
Unilever PLC (UL) Q4 2025 Earnings Call Transcript
Positive2-12
The earnings call indicates positive sentiment with strong growth in emerging markets, consistent U.S. volume growth, and significant productivity savings. The sale of the Packaging business will fund shareholder returns and debt reduction, enhancing financial health. Although there are some concerns, such as flattish European markets and some ambiguity in management responses, these are outweighed by the optimistic guidance, strong brand performance, and strategic focus on innovation and e-commerce. The positive shareholder return plan and stable adjusted EBITDA further support a positive outlook.
Covalon Technologies Ltd. (COV:CA) Q4 2025 Earnings Call Transcript
Unknown12-11
The earnings call presents mixed signals. Positive aspects include a strong cash position, new partnerships, and growth in U.S. Vascular Access. However, declining gross margins, a decrease in EBITDA, and uncertainties in the U.S. Advanced Wound Care channel weigh negatively. The Q&A section highlights management's optimism and strategic plans but lacks clarity on key issues. Given these mixed factors, the stock price is likely to remain stable over the next two weeks, resulting in a neutral sentiment prediction.
UL Report
Frequently Asked Questions
Where does this earnings call transcript come from?
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
How soon is the transcript available after the earnings call ends?
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
Is the transcript edited or altered in any way?
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
Why do some answers appear as “Unclear” or “Inaudible”?
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
Who creates the AI Summary and Key Q&A highlights shown above the transcript?
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.
